Literature DB >> 31486525

Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam.

Thu Thuy Le1, Thi Thanh Huong Nguyen1, Chi Nguyen1, Ngan Ha Tran2, Lan Anh Tran1, Thanh Binh Nguyen1, Nhung Nguyen3, Hoang Anh Nguyen2.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Under-reporting is a major drawback of a voluntary adverse drug reaction reporting system in pharmacovigilance. However, little is known about facilitators and barriers to ADR reporting by healthcare professionals (HCPs) in developing countries. To investigate factors associated with adverse drug reaction (ADR) reporting among HCPs in Vietnam.
METHODS: A cross-sectional survey of 2091 HCPs was conducted in 2015 at 10 hospitals throughout Vietnam. The binary outcome was ever reporting ADRs. Healthcare professionals knowledge, attitude and practice about ADR reporting were measured. Multiple logistic regression analyses examined factors significantly associated with ever ADR reporting.
RESULTS: Overall, 29.3%, 2.2% and 68.4% of the sample were doctors, pharmacists and nurses, respectively. More than half (59.3%) had ever reported any ADR. Facilitators for ADR reporting were educational training (OR = 1.77, 95%CI = 1.42-2.22) and having better knowledge, such as awareness of ADR reporting regulation (OR = 1.63, 95%CI = 1.19-2.21), of reporting time (OR = 1.76, 95%CI = 1.35-2.29) and of necessary information in reporting form (OR = 1.94, 95%CI = 1.53-2.45).Conversely, barriers to non-reporting were unknown of reporting procedure (OR = 0.27, 95%CI = 0.22-0.35), unavailability of reporting form (OR = 0.54, 95%CI = 0.42-0.68) and lack of time (OR = 0.59, 95%CI = 0.46-0.74). WHAT IS NEW AND
CONCLUSION: Given the low ADR reporting rate among HCPs, educational interventions to improve their knowledge and attitude should be prioritized in Vietnam. Additional interventions addressing obstacles (i.e. availability and complexity of reporting form, lack of time) should be considered to improve both the quantity and quality of ADR reporting.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Vietnam; adverse drug reaction; pharmacoepidemiology; pharmacovigilance

Mesh:

Year:  2019        PMID: 31486525     DOI: 10.1111/jcpt.13037

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  5 in total

1.  A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin-converting enzyme inhibitor.

Authors:  Phuong Nguyen Thi Thu; Mai Ngo Thi Quynh; Hung Nguyen Van; Hoi Nguyen Thanh; Khue Pham Minh
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

2.  Assessment of Knowledge, Attitude, and Practice in Adverse Drug Reaction Reporting of Healthcare Professionals in Vietnam: A Cross-Sectional Study.

Authors:  Hai-Yen Nguyen-Thi; Minh-Thu Do-Tran; Thuyen Lu Ngoc; Thuy-Tram Nguyen-Ngoc; Nguyen Dang Tu Le
Journal:  Hosp Pharm       Date:  2021-09-16

3.  Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.

Authors:  Tahmine Salehi; Naiemeh Seyedfatemi; Mohammad Saeed Mirzaee; Maryam Maleki; Abbas Mardani
Journal:  Biomed Res Int       Date:  2021-04-09       Impact factor: 3.411

4.  Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania.

Authors:  Kissa W Mwamwitwa; Adam M Fimbo; Elias M Bukundi; Alex F Nkayamba; Deus Buma; Eva P Muro; Betty A Maganda; Danstan H Shewiyo; Morven C Shearer; Andrew D Smith; Eliangiringa A Kaale
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

5.  Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district.

Authors:  H M Haines; J C Meyer; R S Summers; B B Godman
Journal:  Eur J Clin Pharmacol       Date:  2020-04-15       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.